Key Takeaways
- CEO Lip-Bu Tan suggested Intel may re-enter memory chip production, describing advanced memory architecture as “one of my pet projects”
- The chipmaker closed a $20 billion equity offering on August 10 at $95 per share, marking its first such capital raise since its 1971 public debut
- Former SK Hynix CEO Seok-Hee Lee joined Intel in June as EVP of Intel Foundry, signaling possible memory sector ambitions
- The company has submitted a patent application for “cross-batch memory” (XBM) and is partnering with SoftBank’s SAIMEMORY on Z-Angle Memory (ZAM) development
- INTC shares have surged approximately 180% year-to-date; Wall Street consensus stands at “Hold” with a $107.85 average price target
During an August 13 interview on the TechSurge: Deep Tech VC Podcast, Intel CEO Lip-Bu Tan dropped strong hints about the company potentially re-entering the memory semiconductor sector. INTC shares started trading Friday at $104.56, climbing roughly 3.6% during the session.
Tan characterized innovative memory architecture as “one of my pet projects,” explaining: “I used to not invest in memory because it was kind of a commodity business. But now it has become different.”
While the CEO avoided making any official announcements, the breadcrumbs leading toward a memory business revival are becoming increasingly difficult to overlook.
The commentary coincides with Intel’s substantial $20 billion common stock raise, finalized on August 10. The offering expanded from its original $15 billion goal and executed at $95 per share covering 210.5 million shares. Demonstrating confidence in the strategy, Tan invested $12 million of his personal and family wealth at the offering price.
The funds are designated for capital investments and advanced packaging initiativesāexpenditure categories that align naturally with requirements for memory manufacturing expansion.
Strategic Executive Addition Speaks Volumes
Intel brought aboard Seok-Hee Lee, SK Hynix’s former CEO, as executive vice president of Intel Foundry this past June. During the podcast, Tan explicitly referenced this recruitment: “So you kind of know something that I’m thinking about.”
Lee’s addition lends substantial weight to memory market speculation, although it introduces complexity. Reports indicate SK Hynix is simultaneously negotiating to purchase Intel’s Ohio semiconductor facility for domestic memory manufacturing, creating a potentially conflicted dual relationship for Lee.
Intel has submitted patent documentation for cross-batch memory (XBM), an ultra-high-bandwidth architecture engineered to deliver HBM4-level performance while eliminating the expensive silicon interposer component found in existing HBM configurations. The patent application was submitted on December 26, 2024 and made public on July 2, 2026.
Additionally, Intel is collaborating with SAIMEMORY, a SoftBank subsidiary, on Z-Angle Memory (ZAM) development. ZAM represents a nine-layer stacked DRAM solution marketed as a more energy-efficient option compared to HBM.
Understanding the Target Market Landscape
Micron projects the worldwide HBM market will expand from approximately $35 billion in 2025 to roughly $100 billion by 2028, representing a compound annual growth rate near 40%.
The opportunity is substantial. However, execution presents significant challenges. “There are always many concepts for new forms of memory, but it is extremely difficult for them to go through verification and commercialization and ultimately reach mass production,” noted Lee Jong-hwan, a professor of system semiconductor engineering at Sangmyung University.
Intel reported Q2 2026 revenue of $16.13 billion, representing 25% year-over-year growth. The data center and AI division expanded 59%. Earnings per share reached $0.42, significantly exceeding analyst projections of $0.21.
Institutional stakeholders currently control 64.53% of INTC shares. Vanguard, State Street, Capital World Investors, Geode Capital and Morgan Stanley have all expanded their holdings. The Wall Street consensus price target stands at $107.85, with 32 of 50 analysts maintaining a “Hold” recommendation.
Neither XBM nor ZAM has an established commercialization schedule at this time.


